Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 8Rectal Neoplasms 7Neoplasm Metastasis 5Stomach Neoplasms 3Pancreatic Neoplasms 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Neutropenia 2Bile Duct Neoplasms 2Adenocarcinoma 2mCRC 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Neoplasms 1Nasopharyngeal Carcinoma 1Microsatellite-stable Colorectal Cancer 1Lung Neoplasms 1High-grade Extra Pulmonary Neuroendocrine Cancer 1Gastric Cancer Adenocarcinoma Metastatic 1First-line Treatment 1Esophageal Squamous Cell Carcinoma 1EFS 1Dihydropyrimidine Dehydrogenase Deficiency 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 51Gemcitabine 26toripalimab 20Radiotherapy, Intensity-Modulated 19Fluorouracil 16Capecitabine 16camrelizumab 15Docetaxel 14nimotuzumab 12Radiotherapy 10Drug Therapy 10apatinib 9Nivolumab 9sintilimab 8endostar protein 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Immune Checkpoint Inhibitors 7tislelizumab 6spartalizumab 6Chemoradiotherapy 6Cetuximab 6Bevacizumab 6pembrolizumab 5nedaplatin 5S 1 (combination) 5Radiation 5Paclitaxel 5Endostatins 5anlotinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nasopharyngeal Carcinoma × trifluridine tipiracil drug combination × Clear all
NCT04627961 2020-11-13

A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma

National University Hospital, Singapore

Phase 2 Unknown
33 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡